Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2130-2136
Published online before print September 2, 2004, doi: 10.1161/01.ATV.0000144016.85221.66
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/11/2130    most recent
01.ATV.0000144016.85221.66v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torzewski, M.
Right arrow Articles by Lackner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torzewski, M.
Right arrow Articles by Lackner, K. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2130.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall

A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis

Michael Torzewski; Prapat Suriyaphol; Kerstin Paprotka; Lena Spath; Viola Ochsenhirt; Andrea Schmitt; Shan-Rui Han; Matthias Husmann; Verena B. Gerl; Sucharit Bhakdi; Karl J. Lackner

From the Institutes of Clinical Chemistry and Laboratory Medicine (M.T., V.O., A.S., K.J.L.) and Medical Microbiology and Hygiene (P.S., K.P., L.S., S.-R.H., M.H., S.B.), and the Department of Ophthalmology (V.B.G.), University of Mainz, Germany.

Correspondence to Karl J. Lackner, Institute for Clinical Chemistry and Laboratory Medicine, University of Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany (E-mail lackner{at}zentrallabor.klinik.uni-mainz.de) or Sucharit Bhakdi, Institute of Medical Microbiology and Hygiene, University of Mainz, Hochhaus am Augustusplatz, D-55101 Mainz, Germany (E-mail sbhakdi@uni-mainz.de)

Objective— Functionally interactive proteases of the plasminogen/plasmin and the matrix metalloproteinase (MMP) system degrade and reorganize the extracellular matrix of the vessel wall in atherosclerosis. Here we investigated whether such proteases are able to confer atherogenic properties onto low density lipoprotein by nonoxidative modification.

Methods and Results— Similar to the recently described enzymatically-modified low-density lipoprotein (E-LDL), native LDL exposed to plasmin or matrix MMP-2 or MMP-9 and cholesterylester-hydrolase (CEH) showed extensive deesterification, with ratios of free cholesterol to total cholesterol rising to 0.8 compared with 0.2 in native LDL. When the ratio exceeded 0.6, both plasmin/CEH-LDL and MMP/CEH-LDL fused into larger particles. In parallel, they gained C-reactive protein–dependent complement-activating capacity. E-LDL produced with any protease/CEH combination was efficiently taken up by human macrophages, whereby marked induction of MMP-2 expression by E-LDL was observed. These in vitro findings had their in vivo correlates: urokinase-type plasminogen activator, MMP-2, and MMP-9 were detectable in both early and advanced human atherosclerotic lesions in colocalization with E-LDL.

Conclusions— Plasmin and MMP-2/MMP-9 may not only be involved in remodeling of the extracellular matrix in progressing plaques, but they may also be involved in lipoprotein modification during genesis and progression of atherosclerotic lesions.

Plasmin and matrix metalloproteinases are present in early human atherosclerotic lesions. Both can synergize with cholesterylesterase to transform low-density lipoprotein into a molecule that binds C-reactive protein, activates complement, and induces macrophage foam cell formation. These processes may serve to remove stranded low-density lipoprotein from tissues, but excessive immune activation could trigger atherogenesis.


Key Words: atherosclerosis • lipoproteins • macrophages • metalloproteinases • plasminogen activators




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kremen, R. Krishnan, I. Emery, J. H. Hu, K. I. Slezicki, A. Wu, K. Qian, L. Du, A. Plawman, A. Stempien-Otero, et al.
Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice
PNAS, November 4, 2008; 105(44): 17109 - 17114.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Houard, A. Leclercq, V. Fontaine, M. Coutard, J.-L. Martin-Ventura, B. Ho-Tin-Noe, Z. Touat, O. Meilhac, and J.-B. Michel
Retention and Activation of Blood-Borne Proteases in the Arterial Wall: Implications for Atherothrombosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A3 - A9.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Lee, F. Forudi, G. M. Saidel, and M. S. Penn
Alterations in Internal Elastic Lamina Permeability As a Function of Age and Anatomical Site Precede Lesion Development in Apolipoprotein E-Null Mice
Circ. Res., September 2, 2005; 97(5): 450 - 456.
[Abstract] [Full Text] [PDF]